LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-08-28
Case ID: NM_003000.3_c.73-29del_20260828_182011
Framework: ACMG/AMP 2015
Variant classification summary

NM_003000.3:c.73-29del

SDHB  · NP_002991.2:p.?  · NM_003000.3
GRCh37: chr1:17371411 GA>G  ·  GRCh38: chr1:17044916 GA>G
Gene: SDHB Transcript: NM_003000.3
Final call
VUS
All criteria require review: For research and educational purposes only.
Gene
SDHB
Transcript
NM_003000.3
Protein
NP_002991.2:p.?
gnomAD AF
0.000786436882320673 (v4.1)
ClinVar
Likely benign
OncoKB
Interpretation summary
Generated evidence synthesis
1
No ACMG/AMP criteria were met; with no pathogenic or benign combination threshold satisfied, the variant is classified as a variant of uncertain significance (VUS).
Final determination: With no applied criteria, the generic ACMG/AMP 2015 fallback rules classify the variant as VUS because no pathogenic, likely pathogenic, benign, or likely benign combination threshold is met.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Not met Not met: intronic one-base deletion with no predicted protein change and SpliceAI max delta 0.002, not a null or splice-disrupting variant.
cspec pvs1_generic_framework pvs1_variant_assessment spliceai PMID:25741868
PS1 N/A Not applicable: intronic variant with no predicted protein change, so no same-residue amino-acid comparison is possible.
cspec
PS2 Not assessed Not assessed: no parental genotype or pedigree evidence establishes a de novo origin in the proband.
cspec clinvar
PS3 Not assessed Not assessed: no validated variant-specific functional assay evidence was available.
cspec PMID:25741868
PS4 Not assessed Not assessed: no case-control or enrichment evidence for this variant was available.
cspec
PM1 N/A Not applicable: intronic variant with no protein residue to assess against critical domains or hotspots.
cspec
PM2 Not met Not met: gnomAD v4.1 reports 1253 alternate alleles with two homozygotes, so the variant is not absent from controls.
gnomad_v2 gnomad_v4 gnomad_canada
PM3 N/A Not applicable: SDHB disease is autosomal dominant here, and PM3 requires recessive inheritance.
cspec
PM4 Not met Not met: intronic deletion with no predicted protein-length change, not an in-frame coding indel.
cspec spliceai PMID:25741868
PM5 N/A Not applicable: no predicted amino-acid change, so no pathogenic missense at the same residue to compare.
cspec
PM6 Not assessed Not assessed: no case documentation of presumed de novo occurrence with incomplete parental testing.
cspec clinvar
PP1 Not assessed Not assessed: no family or segregation data were available for this variant.
cspec
PP2 N/A Not applicable: not a missense variant, which PP2 requires.
cspec
PP3 Not met Not met: SpliceAI max delta 0.002 shows no predicted splice effect.
spliceai
PP4 Not assessed Not assessed: no proband or carrier phenotype was provided to assess specificity.
cspec
PP5 Not met Not met: ClinVar has no expert-panel pathogenic or likely pathogenic assertion for this exact variant.
clinvar
BA1 Not met Not met: gnomAD v4.1 maximum population allele frequency 0.00098 (0.098%) is below the 1% BA1 threshold.
cspec gnomad_v2 gnomad_v4 gnomad_canada
BS1 Not met Not met: highest observed frequency 0.098% (gnomAD v4.1 European non-Finnish) is below the 0.3% BS1 threshold.
cspec gnomad_v2 gnomad_v4 gnomad_canada
BS2 Not assessed Not assessed: two gnomAD homozygotes are reported, but their unaffected status could not be confirmed.
gnomad_v4
BS3 Not assessed Not assessed: no functional study demonstrating preserved SDHB function was available.
cspec PMID:25741868
BS4 Not assessed Not assessed: no phenotype-confirmed non-segregation analysis was available.
cspec
BP1 N/A Not applicable: not a missense variant; BP1 applies only to missense changes.
cspec
BP2 Not assessed Not assessed: no genotype or phase data establish an allelic relationship with a pathogenic variant.
cspec
BP3 Not met Not met: no in-frame coding repeat-region indel is established for this intronic deletion.
cspec spliceai PMID:25741868
BP4 Not assessed Not assessed: SpliceAI max delta 0.002 is low, but no verified calibration supports a benign call from this single predictor.
spliceai cspec
BP5 Not assessed Not assessed: no evidence that another molecular diagnosis explains the phenotype.
cspec
BP6 Not met Not met: ClinVar has no expert-panel benign or likely benign assertion for this exact variant.
clinvar
BP7 N/A Not applicable: intronic deletion, not a synonymous coding variant as BP7 requires.
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.